Season 2
In the most recent episode of “There’s More to IT,” host Jason Claybrook discussed the widespread exposure of Per and Polyfluoroalkyl Substances, better known as PFAS, in various aspects of everyday life. His guest was Yuran Li, the director of MS Commercial Strategies at Alternative Biomedical Solutions — a Texas based laboratory. The two talked…
Latest
Season 2
Mastering the Science Behind Creating an IT Department
In this episode of There’s More to IT, host, Jason Claybrook, sat down with David McLaughlin, President & CEO, Columbia Advisory Group. The two discuss McLaughlin’s journey in the field, the importance of the advisory component in CAG’s work, and CAG’s role in higher education. McLaughlin co-founded Columbia Advisory Group a little over 10…
Food & Beverage
Is Holistic Nutrition the Answer for Improving Overall Nutritional Needs?
In the latest episode of the podcast “There’s More to IT,” host Jason Claybrook brings on his wife Niki, and diverges from technology to discuss maintaining healthy-eating habits, as more and more people return to work traveling as pandemic restrictions ease. As a holistic nutrition consultant based in Texas, Claybrook consults clients that have…
Season 2
Technology Leaders Are No Longer Behind the Scenes, They Are Integral for Driving Strategy
Toby Buckalew, Interim CIO, Columbia Advisory Group, is a leading technology strategist with over thirty years of industry experience. Jason Claybrook sat down with Buckalew for an in-depth discussion on his career and insights into the current state of IT management. Buckalew witnessed plenty of technology evolution and innovation during his lengthy career in…
Sciences
The Industry That is Depending on Science and Regulation to Grow
Yuran Li, Director, MS Commercial Strategies, Alternative Biomedical Solutions (ABS), is a biochemist by training. Still, his fascinations with physics, math, and probability have led him down some interesting paths, including some stints in the professional poker world. Lucky for ABS, he chose the science route. Cannabis is a schedule 1 drug classification by the…